Comprehensive prediction of outcomes in patients with ST elevation myocardial infarction (STEMI) using tree-based...

ST elevation myocardial infarction (STEMI), a subtype of acute coronary syndrome, is one of the leading causes of morbidity and mortality. Revascularization using primary percutaneous coronary intervention (PPCI) is the gold standard treatment. Despite the restoration of myocardial blood flow, some patients experience adverse outcomes. Early detection of high-risk patients would facilitate timely management, potentially improving their morbidity, mortality, and quality of life. In-depth characterization of the aortic pressure (AP) waveform may identify a high-risk patient cohort. We present tree-based classifiers and features extracted from the AP signals to identify patients at risk of adverse outcomes. This is a single-center, retrospective cohort study that included 605 eligible STEMI patients [64.2 ± 13.2 years, 71.4 % (432) males] treated with PPCI. Outcomes, including mortality (within 30-day and 1-year), and in-hospital events such as prolonged in-hospital stay (>4 days) for medical reasons, a new diagnosis of heart failure (HF), diuretic use for more than 24 h, intubation-ventilation or BiPAP use, and inotropic and/or vasopressor use, were recorded. We extracted features mainly from denoised AP signals recorded during PPCI, followed by different feature selection algorithms and classification methods to predict outcomes. Various classifiers such as tree-based classifiers, including random forest (RF), adaptive boosting (AdaBoost), extreme gradient boosting (XGBoost), and CatBoost, were used. Using recursive feature elimination (RFE) as the feature selection method and the CatBoost classifier, we achieved a receiver operating characteristic curve's area under the curve (AUC) of 80 % for all outcomes except for the new diagnosis of HF and diuretic use (>24 h). For the new diagnosis of HF and diuretic use (>24 h), the AUC values were 73 % and 79 %, respectively. In conclusion, tree-based classifiers using features extracted from AP traces can effectively identify patients at risk of adverse outcomes in patients with STEMI.